Detalles de la búsqueda
1.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 24(12): 1359-1374, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37926100
2.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046348
3.
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Lancet Oncol
; 20(7): 1023-1034, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31160249
4.
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.
Breast Cancer Res Treat
; 171(1): 65-74, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29766362
5.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600210
6.
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
BMC Cancer
; 16(1): 770, 2016 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716125
7.
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Lancet Oncol
; 13(4): 420-32, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22265698
8.
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Lancet Oncol
; 12(2): 127-36, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21236730
9.
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.
Clin Cancer Res
; 28(7): 1323-1334, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35165099
10.
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.
BMC Med Res Methodol
; 11: 4, 2011 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21223539
11.
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.
Eur J Cancer
; 153: 242-256, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256319
12.
Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.
Stat Methods Med Res
; 27(3): 765-784, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114326
13.
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.
Nat Commun
; 9(1): 896, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29497091
14.
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004).
Eur J Cancer
; 103: 249-258, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30286418
15.
Long-Term Follow-Up of the Intergroup Exemestane Study.
J Clin Oncol
; 35(22): 2507-2514, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467729
16.
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
Radiother Oncol
; 120(1): 114-8, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27046390
17.
Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.
J Clin Oncol
; 33(35): 4138-44, 2015 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26417001
18.
Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.
Radiother Oncol
; 110(3): 416-21, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23953411
19.
Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.
Med Decis Making
; 34(3): 387-402, 2014 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24449433
20.
Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.
Radiother Oncol
; 104(2): 205-12, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22883107